ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 25

Altered Distribution and Enhanced Osteoclastogenesis of Mucosal-associated Invariant T Cells in Gouty Arthritis

Yong-Wook Park1, Young-Nan Cho 1, Hae-Seong Jeong 1, Hye-Mi Jin 1 and Seung-Jung Kee 1, 1Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cell Migration and cytokines, gout, osteoclastogenesis, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Innate Immunity Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Mucosal-associated invariant T (MAIT) cells are subsets of innate invariant T cells and rapidly produce Th1/Th17 cytokines including interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-17 in an innate-like manner. Accumulating data indicate that MAIT cells play an important role in immune defense against infection or cancer. Furthermore, recent studies have extended knowledge regarding the clinical relevance of MAIT cells to cardiometabolic diseases, including metabolic syndrome, obesity, diabetes mellitus, and cardiovascular disease. Here, we investigate the role of MAIT cells in gouty arthritis (GA), one of metabolic diseases, and their effects on osteoclastogenesis.

Methods: Patients with GA (n = 61), hyperuricemia subjects (n = 11), and healthy controls (n = 30) were enrolled in this study. MAIT cells, cytokines, CD69, programmed death-1 (PD-1), and lymphocyte-activation gene 3 (LAG-3) levels were measured by flow cytometry. In vitro osteoclastogenesis experiments were performed using peripheral blood mononuclear cells in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kB ligand.

Results: Circulating MAIT cell levels were significantly reduced in GA patients. However, their capacities for IFN-γ, IL-17, and TNF-α production were preserved. Expression levels of CD69, PD-1, and LAG-3 in MAIT cells were found to be elevated in GA patients. In particular, CD69 expression in circulating MAIT cells was increased by stimulation with monosodium urate monohydrate (MSU) crystals, suggesting that deposition of MSU crystal might contribute to MAIT cell activation. Interestingly, MAIT cells were found to be accumulated in synovial fluid and infiltrated into gouty tophus tissues within joints. Furthermore, activated MAIT cells secreted pro-resorptive cytokines (i.e., IL-6, IL-17, and TNF-α) and facilitated osteoclastogenesis.

Conclusion: This study demonstrates that circulating MAIT cells are activated and numerically deficient in GA patients. In addition, MAIT cells have the potential to migrate to inflamed tissues and induce osteoclastogenesis. These findings provide an important role of MAIT cells in the pathogenesis of inflammation and bone destruction in GA patients.


Disclosure: Y. Park, None; Y. Cho, None; H. Jeong, None; H. Jin, None; S. Kee, None.

To cite this abstract in AMA style:

Park Y, Cho Y, Jeong H, Jin H, Kee S. Altered Distribution and Enhanced Osteoclastogenesis of Mucosal-associated Invariant T Cells in Gouty Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/altered-distribution-and-enhanced-osteoclastogenesis-of-mucosal-associated-invariant-t-cells-in-gouty-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-distribution-and-enhanced-osteoclastogenesis-of-mucosal-associated-invariant-t-cells-in-gouty-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology